General & Patent Counsel / Chief Legal
J.D. (magna cum laude), New York Law School (1998).
M.B.A. (management major), Fairleigh Dickinson University (1997).
Ph.D. (molecular biology/biochemistry), University of Southampton (1991).
B.Sc. (summa cum laude; biochemistry/chemistry), University of Southampton (1988).
Admitted to the bars of New Jersey (1998), New York (1999), Washington, D.C. (2002), Nebraska (2002; inactive), U.S. Supreme Court (2002), U.S. Court of Appeals for the Federal Circuit (1999).
Registered to practice before the U.S. Patent & Trademark Office (1999).
Honors, Awards, And Notable Distinctions
Otto L. Walter Distinguished Legal Writing Award (1998), New York Law School Law Review Member (1995-1996), Articles Editor (1996-1997), and Certificate of Merit recipient (1998), Irving Mariash Scholar, New York Law School (1994-1998), Woodrow Wilson Award for Constitutional Law (1998), NIH Visiting Research Fellow (1991-1992), G.A. Kerkut Prize for Biochemistry (1988), Wellcome Trust Research Scholarship (1987), British Association for the Advancement of Science Award (1987).
Certifications And Professional Affiliations
Regulatory Affairs Certified (R.A.C.) (1998). Chartered Scientist (C.SCI.) (2004). European Chemist (EURCHEM.) (1994). European Professional Biologist (EURPROBIOL.) (1995). Fellow of the Royal Society of Chemistry (C.CHEM., F.R.S.C.) (2001) and the Society for Biology (C.BIOL., F.S.B.) (2001). Member of the New York Academy of Sciences (1994).
Other Advanced Scientific Training
Methods in cell and molecular biology, European Molecular Biology Laboratory, Germany (1990). Computers in protein biochemistry and molecular biology, Maxwell Institute, UK (1991). Advanced methodologies for the analysis of proteins, Autonomous University of Barcelona, Spain (1991). Solid phase methods in DNA sequencing, cloning and protein purification, Royal Institute of Technology, Sweden (1991). Development of the central nervous system, NATO Advanced Study Institute (1991).
Director, Intellectual Property, Sanofi Pasteur, VaxDesign Campus, Orlando, FL. Responsible for IP strategy, management of outside counsel, patent drafting and prosecution (2005-present; in 2010, VaxDesign Corp. was acquired by and is now a wholly owned subsidiary of Sanofi Pasteur).
Advisor, Intellectual Property, NB Capital / Nordic Biotech, Copenhagen, Denmark. Responsible for IP due diligence, validity, infringement, patentability, and freedom-to-operate issues (2005-present).
Consultant, Intellectual Property, Resverlogix Corp., Calgary, Canada. Responsible for IP strategy, patent portfolio management, contract and agreement review (2006-present).
Director, Corporate Development, Paddock Laboratories, Inc., Minneapolis, MN. Responsible for patent and scientific due diligence, patent design arounds, in-licensing, deal prospecting, freedom-to-operate analyses, management of outside counsel, and litigation management. Paragraph IV ANDA strategy (2004-2006).
Scientific and IP Consultant, Nutrition 21, Inc., Purchase, NY. Business plan analysis, scientific writing, editing, deal prospecting, freedom-to-operate, patent strategy, IP due diligence (2004-2006).
Senior Director, Legal Affairs & Company Secretary, Pharmasset, Inc., Atlanta, GA. Responsible for all legal issues, especially management of patent portfolio, patent licensing (in and out), clinical trial contracts, general contract review and negotiation, liability and insurance issues, confidentiality and materials transfer agreements, research and manufacturing / supply agreements employment agreements, trademark filings. Prepared documents for proposed funding round. Supervised outside counsel (2002-2003).
General Counsel, Vice President, Restoragen, Inc., Lincoln, NE (formerly Chief Intellectual Property Counsel). Responsible for all legal issues and competitive intelligence efforts. Managed patent portfolio, trademark filings, freedom-to-operate opinions. Employment agreements, clinical trial contracts, general contract review and negotiation, insurance issues, collaborator and consultant agreements, materials transfer & confidentiality agreements. Participated in preparations of a private placement memorandum and documents for a proposed funding round. Supervised outside counsel (2000-2002).
Patent Counsel, Taro Pharmaceuticals, Hawthorne, NY (since acquired by Sun Pharmaceuticals). Analyzed patents and prepared internal opinions on patents susceptible to paragraph IV ANDA challenge. Member of the R&D and New Product committees. Managed patent portfolio, trademark filings. Supervised outside counsel. Domain name management (1999-2000).
Associate, KAYE SCHOLER, LLP, New York (formerly Summer Associate then Scientific Consultant). Represented major pharma. companies in Hatch-Waxman paragraph IV ANDA lawsuits against generic drug companies. Represented major pharma. company in biotech patent infringement lawsuit. Expert witness and consultant work. Document review and analysis (1997-1999).
Scientific Consultant, WHITMAN BREED ABBOTT & MORGAN, LLP, New York (now WHITE & CASE). Pharmaceutical products liability litigation. Represented pharma. company in suits over an anti-epileptic drug. Expert witness work, medical record analysis, NDA review (1996-1997).
Scientific Consultant, SILLS CUMMIS & GROSS, PC, Newark, NJ. Medical devices products liability litigation. Finding, preparing potential expert witnesses. Daubert challenges to the plaintiffs’ medical and expert witnesses. Scientific literature review, analysis (1994-1996).
Over 79 Published articles